Study Evaluating Safety & Tolerability of Migaldendranib in Healthy Volunteers
NCT07370155
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
MGB 200 mg
DRUG:
MGB 400 mg
DRUG:
MGB 600 mg
Sponsor
Ashvattha Therapeutics, Inc.